May 31, 2007 / 12:21 AM / 11 years ago

Amicus Therapeutics IPO raises $75 mln, in range

NEW YORK, May 30 (Reuters) - Biopharmaceutical firm Amicus Therapeutics on Wednesday raised $75 million in an initial public offering that priced within an expected forecast range.

The 5-million-share offering priced at $15 per share compared with a forecast range of $14 to $16.

Underwriters, led by Morgan Stanley and Merrill Lynch, have the option to purchase an additional 750,000 shares to cover overallotments.

Amicus plans to list its stock on the Nasdaq under the symbol “FOLD.” (FOLD.O), according to an amended filing with the U.S. Securities and Exchange Commission.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below